Melissa Alsina MD

Hematology•Tampa, FL

Assistant Professor of Medicine, University S Fla College of Medicine

Request appointment

12902 USF Magnolia DrTampa, FL 33612
Book by Phone+1(256) 928-2316

Overview of Dr. Alsina

Dr. Melissa Alsina is a hematologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from University of Puerto Rico School of Medicine and has been in practice 38 years. Dr. Alsina accepts several types of health insurance, listed below. She is one of 60 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Hematology. She has more than 100 publications and over 500 citings.

Education & Training

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1992 - 1995
San Juan City HospitalFellowship, Hematology and Medical Oncology, 1991 - 1992
VA Caribbean Healthcare SystemResidency, Internal Medicine, 1988 - 1991
University of Puerto Rico School of MedicineClass of 1988

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2000 - 2028
PR State Medical License 2010 - 2022
OK State Medical License 1996 - 2002
TX State Medical License 1996 - 2002
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2015-2016
CMS Meaningful Use Stage 1 Certification PathNet, Cerner Corporation, 2015-2016
CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2015-2016

Clinical Trials

CI-994 in Treating Patients With Advanced Myeloma
COMPLETED
PHASE2
Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma
COMPLETED
PHASE2
Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)
TERMINATED
PHASE3

Publications & Presentations

PubMed

Chronic graft vs. host disease following post-transplant cyclophosphamide (PTCy) based prophylaxis vs. non-PTCy prophylaxis.
Joseph A Pidala, Jongphil Kim, Jose Laborde, Samantha Knott, Krishnakar Mogili
Blood Advances. 2026-07-21
Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.
Hitomi Hosoya, Arash Velayati, Danai Dima, Alexandria Jensen, Andrew J Portuguese
Blood. 2026-07-08
Patient-reported outcomes after idecabtagene vicleucel vs. ciltacabtagene autoleucel CAR-T for multiple myeloma.
Laura B Oswald, Xiaoyin Li, Lisa M Gudenkauf, Gabe De Avila, David Scheiber-Camoretti
Bone Marrow Transplantation. 2026-07-01

Abstracts/Posters

Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy
Melissa Alsina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
The Result of a Phase 1 Study of Selinexor in Combination with High-Dose Melphalan and Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Melissa Alsina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Panobinostat As a Maintenance Therapy after Autologous Hematopoietic Cell Transplantation for Patients with Multiple Myeloma
Melissa Alsina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

BCMA-Directed CAR-T Therapy Shows Clinical Activity in Multiple MyelomaDecember 7th, 2020
Ash 2020 – Efficacy and Deaths Mark the Car-T Multiple Myeloma RaceDecember 5th, 2020
Bluebird Bio to Present Data from Gene and Cell Therapy Programs During the 62nd American Society of Hematology (ASH) Annual Meeting and ExpositionNovember 5th, 2020

Insurance Accepted

Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS California PowerSelect HMO
BCBS California PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
Blue Shield CA Local Access Plus HMO
Blue Shield California HMO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Connecticare FlexPOS
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Health Net California Large Group PPO
Health Net HMO - Employer Group
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment